RESPIRATORY RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2024-03-04 ms9000001709983423 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肺癌;生信分析
经验分享：20230913 投稿
20230914 送审
20231012 一审返回，审稿意见：大修，两个审稿人
20231211 返修回杂志
20231224 二审送回，审稿意见：小修
20240103 返修回杂志社
20240118 接受
202402 在线发表

总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。
综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别

0 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2023-08-26 kiki123 来自上海

偏重的研究方向：肺腺癌
经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-12-30 ms2000001268287157 来自辽宁省

兄弟们，现在还这么慢吗？？5天还没分配编辑

112 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-03-25 ms9000000537367142

14 reviewer(s) invited 是啥操作?

179 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-12-10 ms9000000537367142 来自四川省

投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧

124 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2023-01-19 ms7000001180831335 来自香港

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肺囊肿
经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。

123 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2023-03-23 loom 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肺腺癌
经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published #lung cancer#

116 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-08-10 yyz

审稿速度:12.0 | 投稿命中率:75.0
经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？

139 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2023-04-14 ST-ya 来自河北省

精彩评论，需要您登录查看

113 1

[GetPortalCommentsPageByObjectIdResponse(id=2191033, encodeId=7239219103356, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肺癌;生信分析 经验分享：20230913 投稿 20230914 送审 20231012 一审返回，审稿意见：大修，两个审稿人 20231211 返修回杂志 20231224 二审送回，审稿意见：小修 20240103 返修回杂志社 20240118 接受 202402 在线发表 总体来说，速度算比较快了。投中的文章整体风格是生信 + 简单验证（免疫组化+临床队列）。 综合其他说审稿速度很慢的评论来看，大胆推测不同编辑的处理稿件效率有很大区别, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81278263956, createdName=ms9000001709983423, createdTime=Mon Mar 04 19:58:36 CST 2024, time=2024-03-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154627, encodeId=ba14215462ed7, content=偏重的研究方向：肺腺癌 经验分享：各位友友，请问这个杂志的投稿链接到底是哪一个，我发现两个投稿的网址，一个是从这个杂志的官网进去的，另一个是从williamhill asia 进去的。哪个才是真的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cdd2019675, createdName=kiki123, createdTime=Sat Aug 26 00:03:50 CST 2023, time=2023-08-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108114, encodeId=94c8210811484, content=兄弟们，现在还这么慢吗？？5天还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=557d5506639, createdName=ms2000001268287157, createdTime=Fri Dec 30 10:27:06 CST 2022, time=2022-12-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1205992, encodeId=a1ed120599249, content=14 reviewer(s) invited 是啥操作?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Fri Mar 25 22:58:35 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105163, encodeId=ac92210516324, content=投稿九个月最后被拒第一轮审稿两个审稿人意见友好编辑给了大修返修回去后编辑找不到原来的审稿人遂重新邀请了一个像是中国人提的问题极度苛刻也有点业余果然中国人还是比较容易为难中国人因为先前两个审稿人一直没找到编辑遂以该审稿人意见拒稿投稿还是蛮看运气的如果遇到审稿人能力不行瞎提意见的就算自个倒霉吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9015376971, createdName=ms9000000537367142, createdTime=Sat Dec 10 00:15:12 CST 2022, time=2022-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2110824, encodeId=68e8211082477, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肺囊肿 经验分享：从投稿到一审花了4个月，最后只回了1个reviewer的意见，二审回去至今三个月，催了又催，刚才给安排了另一个reviewer。这个杂志效率实在太低，谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acd15683126, createdName=ms7000001180831335, createdTime=Thu Jan 19 10:16:25 CST 2023, time=2023-01-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2121295, encodeId=f333212129585, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肺腺癌 经验分享：一开始投这家，才来看评论，以为要很久…结果总体速度还可以 22.12.14 Received 12.15 送审 1.24 一审返回，小修 2.2 修回 2.18 二审返回 2.19 accepted 2.25 published <a href='/topic/show?id=1c1511102cd' target=_blank style='color:#2F92EE;'>#lung cancer#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[TopicDto(id=11102, encryptionId=1c1511102cd, topicName=lung cancer)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39eb8479086, createdName=loom, createdTime=Thu Mar 23 10:06:56 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1237938, encodeId=e715123e9387f, content=审稿速度:12.0 | 投稿命中率:75.0 经验分享：为什么就停在1 Reviewer report received 06 Aug 22，没有邮件提醒和链接？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23625502308, createdName=yyz, createdTime=Wed Aug 10 22:13:11 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125920, encodeId=d714212592058, content=麻烦各位大佬们，我想问一下这本杂志怎么投稿呀，我上传文件总是失败，那个LaTex文档是什么呀，是必须的吗？请大佬们帮帮我吧🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230414/a83e9191267d452ba2489d5498f46465.jpeg, type=image, width=828, height=390)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210616/7bb50ff3877a4de79cf4067e6c136148/0026f853fe094051b0959b6133436f37.jpg, createdBy=cb605526106, createdName=ST-ya, createdTime=Fri Apr 14 15:19:39 CST 2023, time=2023-04-14, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1239445, encodeId=4b9c123944551, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。 我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8a85472802, createdName=ms4000001831714837, createdTime=Thu Aug 18 09:49:46 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-08-18 ms4000001831714837

审稿速度:12.0 | 投稿命中率:50.0
经验分享：效率极低的杂志，慎投。自己在官网写自己平均初审时间36天，实际真实情况是这个的三四倍都不止。
我5月初被别的杂志建议transfer到这个杂志，然后就是长达三个多月的editor assigned阶段，中途换过两次编辑，邮件问，回复是没找到愿意帮助的editor。等了快四个月实在没耐心了，邮件给编辑部说再等一个星期还没进展就退稿，结果看到系统里变成14 reviewer invited。没有撤回邮件，因为审稿状态变了我也没有收到邮件通知，三四个月了都没进展谁会天天盯着系统看。结果没想到过了12个小时，被拒稿了，理由是文章太长。这么低效且脑瘫的杂志真是第一次见，不愧是英国佬的。反正我高攀不起。感谢拒稿，我不等了，投别的效率高的杂志去。转投这个之前我就该来看看大家的经验。着急毕业或者急性子的真的谨慎投稿。

137 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务